Sorafenib, an FDA-approved multi-target kinase inhibitor, is the first-line systemic therapy for advanced HCC
In addition to bad-smelling urine, UTIs often cause: Burning or pain during urination Frequent need to urinate Cloudy or bloody urine Lower abdominal pain Fever or chills (in more serious infections) While Semaglutide is not known to directly cause UTIs, changes in hydration, immune response, and digestion may increase the chance of developing one
In the 1980s, semi-synthetic and recombinant human insulins were developed and in the mid 1990s, insulin analogues became available
For the roughly 49,000 BCBS Massachusetts members actively using GLP-1s, representing 3.6 percent of all policyholders, the clock started ticking immediately
Due to the exploratory nature of the analysis, no statistical analysis or PK modeling was performed on metabolite data
Haydon PG (2001)